NCT00237770View on ClinicalTrials.gov

Prevention of Low Blood Pressure in Persons With Tetraplegia

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
HypotensionSpinal Cord Injury
Interventions
DRUG

N-Nitro L-arginine-methylester (L-NAME)

A non-specific inhibitor of the nitric oxide synthase enzyme.

PROCEDURE

Head-up Tilt maneuver

Participant will be placed onto tilt table and brought to 15 degrees of head up tilt for 60 minutes (intravenous infusion time). After this time, a progressive increase to 45 degrees will be completed with a 10 degree increase every 5 minutes. Participant will remain at 45 degrees for 45 minutes or until symptom onset.

Trial Locations (1)

10468

VA Medical Center, Bronx, The Bronx

All Listed Sponsors
lead

US Department of Veterans Affairs

FED

NCT00237770 - Prevention of Low Blood Pressure in Persons With Tetraplegia | Biotech Hunter | Biotech Hunter